Taiwan · Delayed Price · Currency is TWD Genovate Biotechnology Statistics
Total Valuation
TPEX:4130 has a market cap or net worth of TWD 3.78 billion. The enterprise value is 3.30 billion.
| Market Cap | 3.78B |
| Enterprise Value | 3.30B |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | Aug 20, 2025 |
Share Statistics
TPEX:4130 has 113.75 million shares outstanding. The number of shares has decreased by -0.81% in one year.
| Current Share Class | 113.75M |
| Shares Outstanding | 113.75M |
| Shares Change (YoY) | -0.81% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | 1.21% |
| Float | 82.06M |
Valuation Ratios
The trailing PE ratio is 323.28.
| PE Ratio | 323.28 |
| Forward PE | n/a |
| PS Ratio | 7.67 |
| PB Ratio | 2.74 |
| P/TBV Ratio | 2.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 86.24 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 80.71, with an EV/FCF ratio of -276.15.
| EV / Earnings | 282.18 |
| EV / Sales | 6.69 |
| EV / EBITDA | 80.71 |
| EV / EBIT | n/a |
| EV / FCF | -276.15 |
Financial Position
The company has a current ratio of 5.74, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.74 |
| Quick Ratio | 4.54 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | -0.15 |
| Interest Coverage | 10.15 |
Financial Efficiency
Return on equity (ROE) is 0.83% and return on invested capital (ROIC) is 0.66%.
| Return on Equity (ROE) | 0.83% |
| Return on Assets (ROA) | 0.28% |
| Return on Invested Capital (ROIC) | 0.66% |
| Return on Capital Employed (ROCE) | 0.50% |
| Weighted Average Cost of Capital (WACC) | 5.96% |
| Revenue Per Employee | 2.54M |
| Profits Per Employee | 60,216 |
| Employee Count | 194 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 2.18 |
Taxes
In the past 12 months, TPEX:4130 has paid 1.77 million in taxes.
| Income Tax | 1.77M |
| Effective Tax Rate | 13.17% |
Stock Price Statistics
The stock price has increased by +43.49% in the last 52 weeks. The beta is 0.31, so TPEX:4130's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +43.49% |
| 50-Day Moving Average | 30.20 |
| 200-Day Moving Average | 22.87 |
| Relative Strength Index (RSI) | 58.09 |
| Average Volume (20 Days) | 1,334,580 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4130 had revenue of TWD 492.41 million and earned 11.68 million in profits. Earnings per share was 0.10.
| Revenue | 492.41M |
| Gross Profit | 177.02M |
| Operating Income | 6.92M |
| Pretax Income | 13.45M |
| Net Income | 11.68M |
| EBITDA | 42.03M |
| EBIT | 6.92M |
| Earnings Per Share (EPS) | 0.10 |
Balance Sheet
The company has 481.96 million in cash and 1.84 million in debt, with a net cash position of 480.12 million or 4.22 per share.
| Cash & Cash Equivalents | 481.96M |
| Total Debt | 1.84M |
| Net Cash | 480.12M |
| Net Cash Per Share | 4.22 |
| Equity (Book Value) | 1.38B |
| Book Value Per Share | 12.13 |
| Working Capital | 593.98M |
Cash Flow
In the last 12 months, operating cash flow was 43.79 million and capital expenditures -55.73 million, giving a free cash flow of -11.94 million.
| Operating Cash Flow | 43.79M |
| Capital Expenditures | -55.73M |
| Free Cash Flow | -11.94M |
| FCF Per Share | -0.10 |
Margins
Gross margin is 35.95%, with operating and profit margins of 1.40% and 2.37%.
| Gross Margin | 35.95% |
| Operating Margin | 1.40% |
| Pretax Margin | 2.73% |
| Profit Margin | 2.37% |
| EBITDA Margin | 8.54% |
| EBIT Margin | 1.40% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.31%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 0.31% |
| Dividend Growth (YoY) | -32.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 95.46% |
| Buyback Yield | 0.81% |
| Shareholder Yield | 1.12% |
| Earnings Yield | 0.31% |
| FCF Yield | -0.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 20, 2025. It was a forward split with a ratio of 1.02.
| Last Split Date | Aug 20, 2025 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
TPEX:4130 has an Altman Z-Score of 12.44 and a Piotroski F-Score of 5.
| Altman Z-Score | 12.44 |
| Piotroski F-Score | 5 |